治愈1型糖尿病:我们还在吗?
Christopher Schaaf1, Lori Sussel1
1Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Center, Denver, Colorado, USA.
Diabetes technology & therapeutics
|February 6, 2025
概括
1型糖尿病 (T1D) 研究探索干细胞疗法和免疫隔离装置,以寻找潜在的治疗方法. 目前的干细胞治疗需要免疫抑制,而封装方法在细胞存活和组织反应方面面临挑战.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
背景情况:
- 1型糖尿病 (T1D) 影响着数百万人,胰岛素治疗是当前的标准护理.
- 现有的治疗方法,如小岛移植,由于供体稀缺和免疫抑制要求而面临局限性.
- 对T1D的最终目标是除了管理症状之外的功能性治疗.
研究的目的:
- 审查当前和新兴的治疗策略来治疗1型糖尿病.
- 评估基于干细胞的疗法和免疫隔离技术的潜力.
- 确定T1D治疗研究中的挑战和未来方向.
主要方法:
- 关于1型糖尿病治疗的当前文献的综述.
- 分析基于干细胞的方法,用于贝塔类细胞的生成.
- 评估用于移植的免疫隔离装置技术.
- 对T1D发病延迟的早期免疫疗法的评估.
主要成果:
- 基于干细胞的疗法看起来很有前途,但目前需要免疫抑制剂.
- 免疫隔离装置提供了一个非免疫抑制的替代方案,但面临长期细胞活力和纤维化封装的问题.
- 早期的免疫干预可以延迟T1D的进展.
结论:
- 来自干细胞的β细胞代表了T1D治愈的有希望的途径.
- 克服免疫排斥并确保长期的细胞功能是关键的挑战.
- 持续的研究对于完善干细胞疗法和封装技术对于成功治疗T1D至关重要.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Management and Pharmacotherapy
232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Diabetes: Symptoms, Diagnosis, and Complications
499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Insulin: Dosing Regimen and Adverse Effects
141
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
141


